Re-formatted Data Submission Results In Extension Of FDA Review For Desvenlafaxine Succinate, For The Treatment Of (Medical News Today)
Wyeth (NYSE:WYE) announced today it has been notified by the U.S. Food and Drug Administration (FDA) that the agency has extended by three months the action date for its review of the New Drug Application (NDA) for desvenlafaxine succinate extended release for the treatment of major depressive disorder. [click link for full article]

AMEX Accepts IGI's Plan to Regain Compliance with Continued Listing Standards (Business Wire via Yahoo! Finance)
BUENA, N.J.----Sept. 5, 2006--IGI, INC. a technology company focused on the development of custom products using the patented Novasome delivery technology today announces that the American Stock Exchange has accepted its plan to regain compliance with the continued listing standards of the Exchange.

Water cooler (EETimes)
What's the latest and greatest news heard around the water cooler?